Advertisement
Research Article| Volume 20, ISSUE 4, SUPPLEMENT , S116-S128, July 2011

Download started.

Ok

V. Asymptomatic Cerebrovascular Diseases

  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    ,
    Author Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Yukito Shinohara
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Affiliations
    Director Federation of National Public Service Personnel Mutual Aid Associations Tachikawa Hospital

    The Japan Stroke Society
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Takehiko Yanagihara
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Affiliations
    Professor Emeritus, Osaka University
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Koji Abe
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Affiliations
    Professor, Department of Neurology, Okayama University Medical School
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Toshiki Yoshimine
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Affiliations
    Professor, Department of Neurosurgery, Osaka University Graduate School of Medicine
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Toshiyuki Fujinaka
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Affiliations
    Assistant Professor, Department of Neurosurgery, Osaka University Graduate School of Medicine
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Takayo Chuma
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Affiliations
    Chief, Department of Rehabilitation Medicine, Shiga Medical Center for Adults
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Fumio Ochi
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Affiliations
    Department of Rehabilitation Medicine, Self Defense Forces Central Hospital
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Masao Nagayama
    Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    Affiliations
    Professor, Department of Neurology, International university of Health and Welfare, Atami Hospital
    Search for articles by this author
  • Author Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Akira Ogawa
    Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Affiliations
    Japanese Society of Neurology. President, Iwate Medical University
    Search for articles by this author
  • Author Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Norihiro Suzuki
    Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Affiliations
    Japanese Society of Neurology. Professor, Department of Neurology, Keio University School of Medicine
    Search for articles by this author
  • Author Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Yasuo Katayama
    Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Affiliations
    Japanese Society of Neurological Therapeutics. Professor, Department of Internal Medicine [Divisions of Neurology, Nephrology and Rheumatology], Nippon Medical School
    Search for articles by this author
  • Author Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Akio Kimura
    Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Affiliations
    The Japanese Association of Rehabilitation Medicine. Director, Professor, Keio University Tsukigase Rehabilitation Center
    Search for articles by this author
  • Author Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Takamasa Kayama
    Footnotes
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
    Affiliations
    President, National Cancer Center, and Professor, Department of Neurosurgery, Yamagata University Faculty of Medicine
    Search for articles by this author
  • Author Footnotes
    1 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009, English version.
    2 For the Joint Committee on Japanese Guidelines for the Management of Stroke 2009.
      With the nationwide spread of MRI coupled with the regular brain checkup system in Japan, clinicians often incidentally come across the asymptomatic cerebrovascular diseases during routine medical examinations, and the importance of these disorders has been gradually recognized. For example, asymptomatic cerebral infarctions, also known as “silent brain infarctions,” have recently been identified as an independent risk factor for stroke.1 To reduce the number of the stroke patients and the patients requiring long-term care, asymptomatic cerebral infarction has become one of the diseases to which we should pay more attention, and assessing the appropriate clinical response to it is important. In addition, considering the mortality rate and morbidity are high once such a cerebral aneurysm ruptures, and that clinicians come across asymptomatic cerebrovascular diseases surprisingly frequently,2-5 a set of guidelines presenting the appropriate clinical response and the steps we should take is eagerly awaited.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Journal of Stroke and Cerebrovascular Diseases
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect